CSF3 and glioma: Furthermore, immunostimulatory gene therapy showed higher efficacy in mIDH1 glioma than in wtIDH1 glioma tumor-bearing mice, and this effect depended on G-CSF secreted by mIDH1 glioma stem-like cells (9).